XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenues from Contracts with Customers
 6 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenues from Contracts with Customers REVENUES FROM CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue from Contracts with Customers—The disaggregation of revenue by segment and product is depicted for the periods presented below, and is consistent with how the Company evaluates its financial performance:

Three Months Ended December 31,Six Months Ended December 31,
(in thousands)2021202020212020
Senior:
Commission revenue:
Medicare advantage$99,262 $263,975 $179,345 $312,705 
Medicare supplement2,332 12,743 3,936 20,735 
Prescription drug plan732 1,102 1,001 1,717 
Dental, vision, and health4,920 5,647 8,136 8,370 
Other commission revenue1,954 743 2,854 1,203 
Total commission revenue109,200 284,210 195,272 344,730 
Production bonus and other revenue48,767 31,300 69,015 43,979 
Total Senior revenue157,967 315,510 264,287 388,709 
Life:
Commission revenue:
Term16,126 20,028 32,372 39,772 
Final expense10,886 9,816 35,473 26,274 
Total commission revenue27,012 29,844 67,845 66,046 
Production bonus and other revenue5,768 5,822 12,366 11,048 
Total Life revenue32,780 35,666 80,211 77,094 
Auto & Home:
Total commission revenue5,657 6,491 12,649 15,104 
Production bonus and other revenue478 750 955 1,675 
Total Auto & Home revenue6,135 7,241 13,604 16,779 
Eliminations:
Total commission revenue(1,168)(280)(2,810)(465)
Production bonus and other revenue(733)(572)(2,784)(1,778)
Total Elimination revenue(1,901)(852)(5,594)(2,243)
Total commission revenue140,701 320,265 272,956 425,415 
Total production bonus and other revenue54,280 37,300 79,552 54,924 
Total revenue$194,981 $357,565 $352,508 $480,339 

Contract Balances—After a policy is sold, the Company has no material additional or recurring obligations to the policyholder or the insurance carrier. As such, there are no contract liabilities recorded in the condensed consolidated balance sheets. During the six months ended December 31, 2020, there was no activity in the contract asset balances other than the movement over time between long-term and short-term commissions receivable and accounts receivable as the policy is renewed, as shown on the balance sheet. A roll forward of commissions receivable (current and long term) is shown below for the six months ended December 31, 2021:
(in thousands)
Balance as of June 30, 2021
$845,897 
Commission revenue from revenue recognized212,976 
Net commission revenue adjustment from change in estimate(149,174)
Amounts recognized as accounts receivable(23,894)
Balance as of December 31, 2021
$885,805 

The $149.2 million adjustment from change in estimate includes adjustments from the Company’s reassessment of each of its cohorts’ transaction prices. $145.0 million of the total adjustment is due to the increase in actual lapse rates for Senior MA policies during calendar year 2021 and overall lower persistency from early data received for the January 2022 renewals. Therefore, it was determined that a downward adjustment to Senior MA revenue was probable, and commission revenue was reduced during the three months ended December 31, 2021. Approximately 62%, 28%, and 8% of the adjustment from the change in estimate were from approved policies sold in fiscal years 2021, 2020, and 2019, respectively.

Production Bonuses and Other—During the six months ended December 31, 2021, the Company received advance payments of marketing development funds, which will be amortized over the course of the appropriate fiscal year based on policies sold. As of December 31, 2021, there was an unamortized balance remaining of $2.3 million of fiscal year 2022 marketing development funds recorded in other current liabilities in the condensed consolidated balance sheet.